Trials / Withdrawn
WithdrawnNCT03779295
Laser Therapy for Perioral Dermatitis
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- West Virginia University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Perioral dermatitis is an inflammation of the skin around the mouth. The cause of perioral dermatitis is unknown. Current treatment methods include oral antibiotics and topical calcenurin inhibitors, both of which produce side effects and have been relatively ineffective in the treatment of perioral dermatitis. The investigators hope to assess the efficacy of laser therapy in treatment of perioral dermatitis by using laser therapy on one half of the patients face and having patients apply topical medication (clindamycin) to their face for 8 weeks. The side of their face that receives laser therapy will be randomized. The investigators will assess the efficacy of laser therapy by counting the number of lesions that patients have before and after laser therapy, comparing photos of patient's perioral dermatitis before and after treatment, and having patient's rate their satisfaction of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pulse laser dye therapy (Device name: Candela Family of Pulsed Dye Laser Systems. 501k Number: K050673.) | The face will be split and randomized, one half will receive pulsed laser dye therapy. |
| DRUG | Clindamycin | The entire face (both halves) will receive clindamycin. |
Timeline
- Start date
- 2018-11-01
- Primary completion
- 2019-06-05
- Completion
- 2019-06-05
- First posted
- 2018-12-19
- Last updated
- 2022-03-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03779295. Inclusion in this directory is not an endorsement.